HISTORY
DKD was established to develop and expand the successful research work of its founder, Đào Thị Kim Dung—who has spent more than 30 years pursuing independent scientific research with the aspiration to create effective biological pharmaceutical solutions.
Driven by concerns over the limitations in treating burns, chronic wounds, antibiotic resistance, and endocrine disorders, Ms. Đào Thị Kim Dung gradually built a proprietary technology platform for extracting phospholipid excipients from egg yolk using a solvent-free process—an innovation that opens new directions in regenerative medicine and drug delivery systems.
Two United States patents serve as the foundation for DKD’s integrated ecosystem of research, development, manufacturing, and technology transfer—aimed at bringing next-generation pharmaceutical technologies into real-world clinical practice and community healthcare.
From this core excipient platform, DKD has developed multiple derivative technologies with high applicability, spanning wound care, tissue regeneration, endocrine modulation, lipid metabolism support, and neural regulation—forming a sustainable, multi-application technological ecosystem.
I believe that pharmaceutical science is not merely about formulas and molecules—it is about understanding the human body and giving it the opportunity to heal itself.
MISSION
DKD is committed to researching and developing biological excipients that are safe, effective, and biocompatible, while delivering advanced therapeutic solutions that are cost-efficient, reduce side effects, and are suitable for individual patient conditions.
We collaborate closely with patients, clinicians, and the medical community to shorten formulation development timelines, accelerate clinical application, and ultimately improve quality of life while reducing the burden of treatment.
PHILOSOPHY
“Science centered on human well-being” is the guiding principle behind every decision at DKD.
We believe medicine is not only about treating diseases, but about restoring the value of life. Every DKD product is developed based on deep patient understanding, real-world validation, and a commitment to precision, transparency, and integrity.
We remain dedicated to rigorous and human-centered science—avoiding trends, and never compromising quality for profit. Each formulation represents a convergence of knowledge, ethics, and social responsibility.
OUR TEAM
SCIENTIFIC ADVISORY BOARD
NGHIEM Q. LE
Professor & Former Vice Rector, University of Medicine and Pharmacy at HCMC
NGHIEM Q. LE
Professor & Former Vice Rector, University of Medicine and Pharmacy at HCMC
PhD in Pharmaceutical Sciences. People’s Teacher. Dean of the Faculty of Pharmacy and, from 1999, concurrently Vice Rector, University of Medicine and Pharmacy at Ho Chi Minh City.
Appointed Professor of Pharmaceutical Technology & Drug Formulation in 2007, with more than four decades of experience in drug formulation and advanced drug delivery systems. Author of 52 scientific publications and 4 pharmaceutical textbooks; led national-level research on liposomal drug delivery, sustained-release formulations, bioequivalence, and nanoliposomal paclitaxel for cancer treatment. Vice President, Vietnam Pharmaceutical Association.
KHANH T. PHAM
Pharmaceutical Manufacturing & Formulation Advisor
KHANH T. PHAM
Pharmaceutical Manufacturing & Formulation Advisor
PharmD. Specialization in Pharmaceutical Formulation.
Pharmaceutical manufacturing specialist with extensive experience in pharmaceutical production, formulation development, and technology transfer. Provides strategic guidance on manufacturing processes, production scale-up, GMP practices, and technology transfer to support product commercialization.
OPERATIONS TEAM
VY N. D. NGUYEN
Co-Founder & International Strategy
VY N. D. NGUYEN
Co-Founder & International Strategy
Builds DKD’s global strategy, brand development, strategic partnerships, investment, regulatory strategy, and commercialization — connecting scientific innovation with global healthcare markets.
PHAT T. TO
Clinical Research
PHAT T. TO
Clinical Research
MD, University of Medicine and Pharmacy at Ho Chi Minh City. Bachelor of Medical Laboratory Science, Hong Bang International University. Bachelor of English Language, University of Social Sciences and Humanities, VNU-HCM.
Leads clinical strategy, clinical research, and medical affairs — bridging scientific innovation with real-world clinical practice.
PHONG H. NGUYEN
Product Development
PHONG H. NGUYEN
Product Development
Bachelor of Biotechnology, Da Lat University. Master of Healthcare Management, Hung Vuong University.
Turns scientific innovation into market-ready products through development, manufacturing strategy, and technology transfer.
YEN T. PHAN
Product R&D
YEN T. PHAN
Product R&D
Bachelor of Chemical Engineering, Hanoi University of Science and Technology (HUST).
Leads formulation development, lab research, and technical validation for DKD’s phospholipid platform.
LIEN B. T. NGUYEN
Business Development
LIEN B. T. NGUYEN
Business Development
Bachelor of Business Administration, College of Foreign Economic Relations.
Drives business development, strategic partnerships, and customer engagement to support DKD’s commercial growth.
VAN B. NGUYEN
Finance & Accounting
VAN B. NGUYEN
Finance & Accounting
Bachelor of Accounting and Auditing, HUTECH University.
Manages financial operations, budgeting, regulatory compliance, and reporting for DKD’s sustainable growth.
LAN D. NGUYEN
Regional Development
LAN D. NGUYEN
Regional Development
Bachelor of International Business, National Economics University (NEU).
Supports regional partnerships and market expansion to strengthen DKD’s presence across Vietnam.
THOA T. DAO
Clinical Operations
THOA T. DAO
Clinical Operations
Bachelor of Foreign Languages, Hanoi Open University. General Medical Doctor Assistant, Hanoi Medical School.
Responsible for clinical operations, physician engagement, medical coordination, and implementation of clinical programs, supporting the translation of DKD’s technology into real-world healthcare practice.

Tiếng Việt